Skip to content

The effect of maternal empowerment program on the colostomy complications in infants and tolerance of mother's distress

The effect of maternal empowerment program on the colostomy complications in infants and tolerance of mother's distress

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191207045633N1
Enrollment
60
Registered
2019-12-28
Start date
2019-03-21
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of the colostomy. Colostomy status

Interventions

Intervention 1: Intervention group:: Three 45 minute sessions of mother empowerment for neonatal colostomy including: first session of maternal information, gastrointestinal complications and complica

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 90 Days

Inclusion criteria

Inclusion criteria: for Infant: Infant Age 0 to 90 Days - Infant's Clinical Stability (Including Heart Rate and Breathing) - Need for Colostomy in Treatment - No Other Abnormalities (like Metabolic Disorders, Immune Deficiency and Chemotherapy Neonates PerTerm and Term - Infant's Clinical Stability (Including Heart Rate and Breathing Need for Colostomy in Treatment No Other Abnormalities (like Metabolic Disorders, Immune Deficiency and Chemotherapy For the mother: consent to participate in the study No psychiatric disorders ( depression and hoarseness based on physical symptoms and confession of the spouse or accompanying health and illness status) based on self-reported and physical disability or disabling illnesses affecting infant care) Is not addicted to self-expression. Has reading and writing skills.

Exclusion criteria

Exclusion criteria: Physical and mental disorders affecting the care of the baby During the study, according to the physician, a Diagnosis of one of the metabolic diseases,Immune deficiency or chemotherapeutic defects, etc. unwillingness to continue working, not attending one of the three training sessions, not attending to assess the complications of the exclusion criteri for the infant: neonatal death a Diagnosis of one of the metabolic diseases,Immune deficiency or chemotherapeutic defects, etc.

Design outcomes

Primary

MeasureTime frame
Complications Ostomy -. Timepoint: For complications of ostomy, one, two, three months after ostomy, empowerment. Method of measurement: Dermatologic distress tolerance questionnaire.;Tolerance of mother distress. Timepoint: Before intervention - Immediately after intervention - One and two months after intervention. Method of measurement: DTS distress tolerance questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehnam Vashani Hamid Reza

Mashhad University of Medical Sciences

behnamhr@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026